<?xml version="1.0" encoding="UTF-8"?>
<p id="Par58">As pregnancy progresses, the levels of hormonal factors, such as progesterone, estrogen and human chorionic gonadotropin (HCG), change dramatically and are considerably higher than at any other time [
 <xref ref-type="bibr" rid="CR96">96</xref>, 
 <xref ref-type="bibr" rid="CR112">112</xref>, 
 <xref ref-type="bibr" rid="CR113">113</xref>], potentially also contributing to poor outcomes. The levels of the three hormonal factors were found to be higher in HEV-positive pregnant FHF patients than in HEV-negative patients or controls [
 <xref ref-type="bibr" rid="CR104">104</xref>]. Increased estradiol in the serum of HEV-infected pregnant women promoted viral replication [
 <xref ref-type="bibr" rid="CR114">114</xref>, 
 <xref ref-type="bibr" rid="CR115">115</xref>], which may be associated with poor outcomes [
 <xref ref-type="bibr" rid="CR86">86</xref>]. In addition, a high level of estrogen was found to be related to preterm delivery, low birth weight infants and fetal mortality through placental dysfunction in pregnant women with HEV infection [
 <xref ref-type="bibr" rid="CR116">116</xref>].
</p>
